Testing effectiveness (Phase 2)Study completedNCT00376961
What this trial is testing
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Who this might be right for
Lymphoma
SWOG Cancer Research Network 68